Page 112 - Remedial Andrology
P. 112

Analyse the blood gas parameters from blood aspirated from the penis to differentiate   Strong
                        between ischaemic and non-ischaemic priapism.
                        Perform colour duplex ultrasound of the penis and perineum before aspiration to   Strong
                        differentiate between ischaemic and non-ischaemic priapism.
                        In cases of prolonged ischaemic priapism or refractory priapism, magnetic resonance   Weak
                        imaging of the penis may be used as an adjunct to predict smooth muscle viability.
                        Perform selected pudendal arteriogram when embolisation is planned for the management   Strong
                        of non-ischaemic priapism.

                        9.1.3   Disease management
                        Acute ischaemic priapism is a medical emergency. Urgent intervention is mandatory and should follow a
                        stepwise approach. The aim of any treatment is to restore penile detumescence, without pain, in  order to
                        prevent corporal smooth muscle fibrosis and subsequent ED.

                        Figure 13: Medical and surgical management of ischaemic priapism

                        The treatment is sequential and physicians should move on to the next stage if treatment fails.


                          Ini al conserva ve measures
                          •  Local anaesthesia of the penis
                          •  Insert wide bore bu erfly (16-18 G) through the glans into the corpora cavernosa
                          •  Aspirate cavernosal blood unl bright red arterial blood is obtained







                          Cavernosal irriga on
                          •  Irrigate with 0.90% w/v saline soluon







                          Intracavernosaltherapy
                          •  Inject intracavernosaladrenoceptoragonist
                          •  Current first-line therapy is phenylephrine* with aliquots of 200 µg being injected every 3-5 minutes
                            unl detumescence is achieved (maximum dose of phenylephrine is 1mg within 1hour) *







                          Surgical therapy
                          •  Surgical shunng
                          •  Consider primary penile implantaon if priapism has been present for more than 48 hours


                        (*) Dose of phenylephrine should be reduced in children. It can result in significant hypertension and should be
                        used with caution in men with cardiovascular disease. Monitoring of pulse and blood pressure is advisable in
                        all patients during administration and for 1 hour afterwards. Its use is contraindicated in men with a history of
                        cerebro-vascular disease and significant hypertension.

                        9.1.3.1   Medical Management
                        Evidence Acquisition
                        The studies that were identified after abstract screening and used for this literature review pertaining to
                        medical management are reported in the table in Appendix 1. Most of these studies were retrospective
                        case series without an available protocol. Additionally, several limitations were encountered during their
                        assessment,  including  small  study  samples,  unclear  definitions  of  conditions,  interventions  and  outcomes,




                        SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021                                       111
   107   108   109   110   111   112   113   114   115   116   117